1 Lozano R，Naghavi M，Foreman K，et al. Global and

regional mortality from 235 causes of death for 20 age

groups in 1990 and 2010：a systematic analysis for the

Global Burden of Disease Study 2010[J]. Lancet，2012，

380：2095-2128.

2 Katagir i H，Yamada T，Oka Y. Adiposity and

cardiovascula r disorders：disturbance of the

regulatory system consisting of humoral and neuronal

signals[J]. Circ Res，2007，101：27-39.

3 Cher ubini A，Ruggiero C，Polidor i MC，et al.

Potential markers of oxidative stress in stroke[J]. Free

Radic Biol Med，2005，39：841-852.

4 Kugiyama K，Kerns SA，Mor r iset t JD，et a l.

Impairment of endothelium-dependent ar terial

relaxation by lysolecithin in modified low-density

lipoproteins[J]. Nature，1990，344：160-162.

5 Stiko-Rahm A，Hultgårdh-Nilsson A，Regnström J，

et al. Native and oxidized LDL enhances production

of PDGFAA and the surface expression of PDGF

receptors in cultured human smooth muscle cells[J].

Arterioscler Thromb，1992，12：1099-1109.

6 Yui S，Sasaki T，Miyazaki A，et al. Induction of

murine macrophage growth by modified LDLs[J].

Arterioscler Thromb，1993，13：331-337.

7 Yue W，Wang A，Liang H，et al. Association between

carotid intima-media thickness and cognitive

impairment in a Chinese stroke population：A crosssectional

study[J]. Sci Rep，2016，6：19 556.

8 Vi r ma n i R，La d i c h ER，Bu r ke A P，e t a l .

Histopathology of carotid atherosclerotic disease[J].

Neurosurgery，2006，59：S219-227; discussion S3-13.

9 Chen KC，Liao YC，Wang JY，et al. Oxidized lowdensity

lipoprotein is a common risk factor for

cardiovascular diseases and gastroenterological

cancers via epigenomical regulation of microRNA-

210[J]. Oncotarget，2015，6：24 105-24 118.

10 Ehara S，Ueda M，Naruko T，et al. Elevated levels

of oxidized low density lipoprotein show a positive

relationship with the severity of acute coronary

syndromes[J]. Circulation，2001，103：1955-1960.

11 Vibo R，Kõrv J，Roose M，et al. Acute phase proteins

and oxidised low-density lipoprotein in association

with ischemic stroke subtype，severity and outcome[J].

Free Radic Res，2007，41：282-287.

12 Yao M，Herve D，Allili N，et al. NIHSS scores in

ischemic small vessel disease：a study in CADASIL[J].

Cerebrovasc Dis，2012，34：419-423.

13 Ryglewicz D，Rodo M，Roszczynko M，et al.

Dynamics of LDL oxidation in ischemic stroke

patients[J]. Acta Neurol Scand，2002，105：185-188.

14 Uno M，Harada M，Takimoto O，et al. Elevation

of plasma oxidized LDL in acute stroke patients is

associated with ischemic lesions depicted by DWI and

predictive of infarct enlargement[J]. Neurol Res，2005，

27：94-102.

15 Jialal I. Evolv ing l ipoprotei n r i s k factor s：

lipoprotein(a) and oxidized low-density lipoprotein[J].

Clin Chem，1998，44：1827-1832.

16 Steinberg D. Low density lipoprotein oxidation and

its pathobiological significance[J]. J Biol Chem，1997，

272：20 963-20 966.

17 Guldiken B，Guldiken S，Turgut B，et al. The roles

of oxidized low-density lipoprotein and interleukin-6

levels in acute atherothrombotic and lacunar ischemic

stroke[J]. Angiology，2008，59：224-229.

18 Fang R，Zhang N，Wang C，et al. Relations between

plasma ox-LDL and carotid plaque among Chinese

Han ethnic group[J]. Neurol Res，2011，33：460-466.

19 Redgrave JN，Lovett JK，Rothwell PM. Histological

features of symptomatic carotid plaques in relation to

age and smoking：the oxford plaque study[J]. Stroke，

2010，41：2288-2294.

20 Cipollone F，Iezzi A，Fazia M，et al. The receptor

RAGE as a progression factor amplifying arachidonatedependent

inf lammatory and proteolytic response

in human atherosclerotic plaques：role of glycemic

control[J]. Circulation，2003，108：1070-1077.

21 Rajava shi s th TB，Liao JK，Gal is ZS，e t a l .

Inf lammatory cytokines and oxidized low density

lipoproteins increase endothelial cell expression of

membrane type 1-matrix metalloproteinase[J]. J Biol

Chem，1999，274：11 924-11 929.

22 Dwivedi A，Anggard EE，Carrier MJ. Oxidized LDLmediated

monocyte adhesion to endothelial cells does

not involve NF kappaB[J]. Biochem Biophys Res

Commun，2001，284：239-244.